BioSpace News Archive

BioCapital

Amatus Health’s Director of Licensing and Compliance to Speak on Eric Bolling Town Hall: Our Voice, Our Future

Nicholas Albaugh, Amatus Health’s Director of Licensing and Compliance, will be speaking on behalf of Amatus as a treatment provider during a panel discussion on the opioid epidemic at University of Maryland Baltimore County on March 14 at 7 P.M.

March 14, 2019
·
1 min read
Business

Hanger Reports Fourth Quarter 2018 Results and Provides 2019 Outlook

Company anticipates growth in 2019 revenue and earnings, driven by the patient care segment

March 14, 2019
·
29 min read
Drug Development

Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Ready-to-Use Glucagon to Address Exercise-Induced Hypoglycemia

Xeris Pharmaceuticals, Inc. announced that it has now begun dosing patients in a Phase 2 trial with its ready-to-use, room-temperature stable liquid glucagon in patients with Type 1 diabetes who experience episodes of exercise-induced hypoglycemia.

March 14, 2019
·
6 min read
Business

AVEO Reports Full Year 2018 Financial Results and Provides Business Update

AVEO Oncology reported financial results for the full year ended December 31, 2018 and provided a business update.

March 14, 2019
·
15 min read
Business

Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results

Introduces new integrated commercial strategy to support physician adoption of the DABRA laser system and build long-term customer relationships

March 14, 2019
·
14 min read
Business

BioTime Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

BioTime, Inc., a clinical-stage biotechnology company focused on degenerative diseases, reported financial and operating results for the fourth quarter and full year ended December 31, 2018.

March 14, 2019
·
26 min read
Business

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Introduces Full Year 2019 Outlook

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, reported financial results for the fourth quarter and full year ended December 31, 2018.

March 14, 2019
·
16 min read
Deals

Spero Therapeutics Announces Fourth Quarter and Full Year 2018 Operating Results and Provides Pipeline Review

Anticipated 2019 Events include Enrollment in the Planned SPR994 Pivotal Phase 3 Clinical Trial and Top-Line Data from SPR720 and SPR206 Phase 1 Clinical Trials in 2H19

March 14, 2019
·
11 min read
Deals

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2018, as well as recent business highlights.

March 14, 2019
·
9 min read
Policy

Illinois Poised to Become 8th State to Raise Tobacco Age to 21

Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids

March 14, 2019
·
2 min read